Here is the latest stock price and chart of GOODRICKE. For more details, see the GOODRICKE company fact sheet and quarterly results.
Know More: Which way are the markets & the mutual fund industry headed?
Live BSE Quotes | Jan 25, 2021 (Close) | ||
---|---|---|---|
Price (Rs)260.55 | Open (Rs) 260.00 | High (Rs) 263.90 | Low (Rs) 254.90 |
% Change1.72 | Volume 6,167 | Value (Rs) 1,588,567 | 52-Week H/L 322.70 / 90.00 |
Live NSE Quotes |
---|
Not listed |
Change | |||||
---|---|---|---|---|---|
1 Day 1.72% | 1 Month -4.75% | 3 Months -7.93% | 1 Year 26.14% | 5 Years (CAGR)* 8.81% | 10 Years (CAGR)* 6.11% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 7.56 | P/E Ratio (x) 34.48 | Market Cap (Rs m) 5,627.88 | P/BV (x) 1.83 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
![]() |
||
S&P BSE SENSEX ![]() |
||||||
PERIOD |
GOODRICKE last traded price was up 1.7% to Rs 260.6 on the BSE. The total volume of shares traded was 0.0 m.
Overall, the benchmark S&P BSE SENSEX was at 48,347.6 (down 1.1%).
Over the last 30 days, the GOODRICKE share price is up 4.1%. And over the last one year, GOODRICKE share price is up 27.5%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.
For the quarter ended December 2019, GOODRICKE has posted a net profit of Rs 11 m (down 80.8% YoY). Sales on the other hand came in at Rs 3 bn (up 4.6% YoY). Read on for a complete analysis of GOODRICKE's quarterly results.
Does the company with one of the fastest-growing QSR chains in India have sound prospects?
For the quarter ended June 2019, GOODRICKE has posted a net profit of Rs 58 m (down 18.5% YoY). Sales on the other hand came in at Rs 2 bn (up 17.6% YoY). Read on for a complete analysis of GOODRICKE's quarterly results.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.
Our ace stock picker is ready to capitalise on a big growth opportunity.
More